PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

Jyoti D. Patel, Mark A. Socinski, Edward B. Garon, +15

Journal of Clinical Oncology

Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Mark R. Olsen, +14

Journal of Clinical Oncology

Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study

Nicholas J. Vogelzang, Mark R. Olsen, Joshua J. McFarlane, +22

Clinical Genitourinary Cancer

Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial

H. Ian Robins, Anne O’Neill, Mark R. Gilbert, +4

Cancer Chemotherapy and Pharmacology

Neuro-oncologyThromboembolic EventsRadiation TherapyGlioblastoma MultiformeMedicine +8

Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920

Hamid Emamekhoo, Mark R. Olsen, Bradley Curtis Carthon, +15

Cancer

Randomized phase II multicenter study of the efficacy and safety of sunitinib on the 4/2 versus continuous dosing schedule as first-line therapy of metastatic renal cell carcinoma: Renal EFFECT Trial.

Robert J. Motzer, Thomas E. Hutson, Mark R. Olsen, +7

Journal of Clinical Oncology

First-line TherapyUrologyOncologyLba308 BackgroundGenitourinary Cancer +11

PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

Rahul Aggarwal, Glenn Heller, David W. Hillman, +69

Journal of Clinical Oncology

Safety and efficacy of nivolumab plus ipilimumab (NIVO+IPI) in patients with advanced renal cell carcinoma (aRCC) with brain metastases: Interim analysis of CheckMate 920.

Hamid Emamekhoo, Mark R. Olsen, Bradley Curtis Carthon, +13

Journal of Clinical Oncology

Brain MetastasesHigh-grade GliomasNeuro-oncologyOncologyGenitourinary Cancer +18

Orthomanganation of the iminophosphorane Ph3PNPh, and of triphenylarsine-oxide and -sulfide

Mark A. Leeson, Brian K. Nicholson, Mark R. Olsen

Journal of Organometallic Chemistry

Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study

Joshua J. McFarlane, Mark D. Kochenderfer, Mark R. Olsen, +17

Clinical Genitourinary Cancer